PGBD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.642800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.338800E-01
Normal-vs-Stage2
9.995700E-02
Normal-vs-Stage3
1.114850E-01
Normal-vs-Stage4
4.529800E-01
Stage1-vs-Stage2
5.840800E-01
Stage1-vs-Stage3
5.269200E-01
Stage1-vs-Stage4
6.913600E-01
Stage2-vs-Stage3
7.044600E-01
Stage2-vs-Stage4
3.345400E-01
Stage3-vs-Stage4
2.661600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.003400E-01
Normal-vs-AfricanAmerican
2.115000E-01
Normal-vs-Asian
1.100350E-01
Caucasian-vs-AfricanAmerican
8.328000E-01
Caucasian-vs-Asian
3.749800E-01
AfricanAmerican-vs-Asian
5.978200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.617200E-01
Normal-vs-Female
4.987600E-01
Male-vs-Female
2.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.699200E-01
Normal-vs-Age(41-60Yrs)
4.506600E-01
Normal-vs-Age(61-80Yrs)
3.790600E-01
Normal-vs-Age(81-100Yrs)
1.432350E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.699800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.982400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.590000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.415800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.607850E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.472820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.203990E-02
Normal-vs-Daily Drinker
3.848600E-01
Normal-vs-Weekly Drinker
3.272000E-01
Normal-vs-Occasional Drinker
9.235600E-01
Normal-vs-Social Drinker
4.440000E-01
Non Drinker-vs-Daily Drinker
2.479800E-01
Non Drinker-vs-Weekly Drinker
1.799980E-02
Non Drinker-vs-Occasional Drinker
9.860200E-02
Non Drinker-vs-Social Drinker
1.866270E-02
Daily Drinker-vs-Weekly Drinker
6.124000E-01
Daily Drinker-vs-Occasional Drinker
3.457000E-01
Daily Drinker-vs-Social Drinker
5.547400E-01
Weekly Drinker-vs-Occasional Drinker
5.196800E-01
Weekly Drinker-vs-Social Drinker
9.111000E-01
Occasional Drinker-vs-Social Drinker
5.716400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.871200E-01
Normal-vs-Grade 2
9.303600E-01
Normal-vs-Grade 3
9.710800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.486810E-01
Grade 1-vs-Grade 3
9.152000E-02
Grade 1-vs-Grade 4
6.871200E-01
Grade 2-vs-Grade 3
4.197800E-01
Grade 2-vs-Grade 4
9.303600E-01
Grade 3-vs-Grade 4
9.710800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.545700E-02
Normal-vs-NonDiabetic
5.021400E-01
Diabetic-vs-NonDiabetic
1.367640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.806030E-01
Normal-vs-NoPancreatitis
3.950400E-01
Pancreatitis-vs-NoPancreatitis
6.973400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.625400E-01
Normal-vs-N1
1.251820E-01
N0-vs-N1
2.411200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.916230E-02
Normal-vs-TP53-NonMutant
7.529600E-01
TP53-Mutant-vs-TP53-NonMutant
2.560600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
